Oral features of mucocutaneous disorders

Journal of Periodontology

Volumn 74, Issue 10, 2003, Pages 1545-1556

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; AZATHIOPRINE; BECLOMETASONE DIPROPIONATE; BETAMETHASONE; CLOBETASOL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DEXAMETHASONE; FLUOCINONIDE; GOLD; GRISEOFULVIN; LEVAMISOLE; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RETINOID; TACROLIMUS; TETRACYCLINE DERIVATIVE; THALIDOMIDE; TRIAMCINOLONE; ULOBETASOL PROPIONATE; UNINDEXED DRUG;

BULLOUS SKIN DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; DENTIST; DESQUAMATION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; GINGIVITIS; GRAFT VERSUS HOST REACTION; HUMAN; INTERNATIONAL COOPERATION; LICHEN PLANUS; LUPUS ERYTHEMATOSUS; MEDICAL PROFESSION; MEDICAL SPECIALIST; PARAMEDICAL PERSONNEL; PATIENT CARE; PEMPHIGUS VULGARIS; PERIODONTAL DISEASE; PERIODONTICS; PERIODONTIUM; PHYSICIAN; PSORIASIS; REVIEW; STOMATITIS; TEAMWORK; TOOTH PLAQUE;

EID: 0344466464     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2003.74.10.1545     Document Type: Review

References (219)

1. Holmstrup P. Non-plaque induced gingival lesions. Ann Periodontol 1999;4:20-31.
2. Nisengard RJ. Periodontal implications: Mucocutaneous disorders. Ann Periodontol 1996;1:401-438.
3. Nisengard RJ, Rogers III RS. The treatment of desquamative gingival lesions. J Periodontol 1987;58:167-172.
4. Rogers RS, Sheridan PJ, Jordon RE. Desquamative gingivitis. Clinical, histopathologic and immunopathologic investigations. Oral Surg Oral Med Oral Pathol 1976;42:316-327.
5. Rogers RS, Sheridan PJ, Nightingale SH. Desquamative gingivitis: Clinical, histopathologic, immunopathologic, and therapeutic observations. J Am Acad Dermatol 1982; 7:729-735.
6. Helander SD, Rogers RS. The sensitivity and specificity and direct immunofluoresence testing in disorders of mucous membranes. J Am Acad Dermatol 1994;30:65-75.
7. Chaiyarit P, Kafrawy AH, Miles DA, Zunt SL, Van Dis ML, Gregory RL. Oral lichen planus: An immunohistochemical study of heat shock proteins (HSPs) and cytokeratins (CKs) and a unifying hypothesis of pathogenesis. J Oral Pathol Med 1999;28:210-215.
8. Hakkinen L, Kainulainen T, Salo T, Grenman R, Larjava H. Expression of integrin alpha9 subunit and tenascin in oral leukoplakia, lichen planus, and squamous cell carcinoma. Oral Dis 1999;5:210-217.
9. Simpson HE. The age and sex incidence and anatomical distribution of oral leukoplakia and lichen planus. Br J Dermatol 1957;69:178-180.
10. Mollaoglu N. Oral lichen planus: A review. Br J Oral Maxillofac Surg 2000;38:370-377.
11. Nanda A, Al-Ajmi HS, Al-Sabah H, Al-Hasawi F, Alsaleh QA. Childhood lichen planus: A report of 23 cases. Pediatr Dermatol 2001;18:1-4.
12. Alam F, Hamburger J. Oral mucosal lichen planus in children. Int J Paediatr Dent 2001;11:209-214.
13. Axell T, Rundquist L. Oral lichen planus - A demographic study. Community Dent Oral Epidemiol 1987;15:52-56.
14. Arndt KA. Lichen planus. In: Fitzpatrick TB, ed. Dermatology in General Medicine. New York: McGraw Hill Book Co; 1979.
15. Conklin RJ, Blasberg B. Oral lichen planus. Dermatol Clin 1987;5:663-673.
16. Thorn JJ, Holstrup P, Rindum H, Pindborg JJ. Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients. J Oral Pathol Med 1988;17:213-318.
17. Silverman S Jr., Bahl S. Oral lichen planus update: Clinical characteristics, treatment responses and malignant transformation. Am J Dent 1997;10:259-263.
18. Eisen D. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:431-436.
19. Abraham SC, Ravich WJ, Anhalt GJ, Yardley JH, Wu TT. Esophageal lichen planus: Case report and review of the literature. Am J Surg Pathol 2000;24:1678-1682.
20. Eisen D. The vulvovaginal-gingival syndrome of lichen planus. The clinical characteristics of 22 patients. Arch Dermatol 1994;130:1379-1382.
21. Cribier B, Ndiaye I, Grosshans E. Peno-gingival syndrome. A male equivalent of vulvo-vaginal-gingival syndrome? Rev Stomatol Chir Maxillofac 1993;94:48-51.
22. Walker DM. The inflammatory infiltrate in lichen planus lesions. An autoradiographic and ultrastructural study. J Oral Pathol Med 1976;5:277-286.
23. Dockrell HM, Greenspan JS. Histochemical identification of T cells in oral lichen planus. Oral Surg Oral Med Oral Pathol 1979;48:42-46.
24. Regezi JA, Deegan MJ, Hayward JR. Lichen planus: Immunologic and morphologic identification of the submucosal infiltrate. Oral Surg Oral Med Oral Pathol 1978;46:44-52.
25. Yih WY, Maier T, Kratochvil FJ, Zieper MB. Analysis of desquamative gingivitis using direct immunofluorescence in conjunction with histology. J Periodontol 1998;69:678-685.
26. Raghu AR, Rao NN. Immunofluorescence in oral lichen planus and oral lichenoid reaction. A review. Indian J Dent Res 2001;12:29-34.
27. Nieboer C. The reliability of immunofluorescence and histopathology in the diagnosis of discoid lupus erythematosus and lichen planus. Br J Dermatol 1987;116:189-198.
28. Kilpi AM, Rich AM, Radden BG, Reade PC. Direct immunofluorescence in the diagnosis of oral mucosal disease. Int J Oral Maxillofac Surg 1988;17:6-10.
29. Schiodt M, Holmstrup P, Dabelsteen E, Ullman S. Deposits of immunoglobulins, complement, and fibrinogen in oral lupus erythematosus, lichen planus, and leukoplakia. Oral Surg Oral Med Oral Pathol 1981;51:603-608.
30. Thornhill MH. Immune mechanisms in oral lichen planus. Acta Odontol Scand 2001;59:174-177.
31. Silverman S Jr., Eversole LR. Immunopathologic mucosal lesions. In: Silverman S Jr., Eversole LR, Truelove El, eds. Essentials of Oral Medicine. Hamilton, ON: B.C. Decker Inc.; 2001.
32. Little MC, Griffiths CEM, Watson REB, Pemberton M, Thornhill MH. Activation or oral keratinocytes by mercuric chloride: Relevance to dental amalgam-induced oral lichenoid reactions. BrJ Dermatol 2001;144:1024-1032.
33. Wright JM. Oral manifestations of drug reactions. Dent Clin North Am 1984;28:529-543.
34. Kilpi AM, Rich AM, Radden BG, Reade PC. Direct immunofluorescence in the diagnosis of oral mucosal diseases. Int J Oral Maxillofac Surg 1988;17:6-10.
35. Eversole LR, Ringer M. The role of dental restorative metals in the pathogenesis of oral lichen planus. Oral Surg Oral Med Oral Pathol 1984;57:383-387.
36. Bolewska J, Hansen HJ, Holmstrup P, Pindborg JJ, Stangerup M. Oral mucosal lesions related to silver amalgam restorations. Oral Surg Oral Med Oral Pathol 1990;70:55-58.
37. Bolewska J, Holmstrup P, Moller-Madsen B, Kenrad B, Danscher G. Amalgam associated mercury accumulations in normal oral mucosa, oral mucosal lesions of lichen planus and contact lesions associated with amalgam. J Oral Pathol Med 1990;15:39-42.
38. Bratel J, Hakelberg M, Jontell M. Effect of replacement of dental amalgam on oral lichenoid reactions. J Dent 1996;24:41-45.
39. Henricksson E, Mattsson U, Hakamsson J. Healing of lichenoid reactions following removal of amalgam. A clinical follow-up. J Clin Periodontol 1995;22:287-294.
40. Holmstrup P. Oral mucosa and skin reactions related to amalgam. Adv Dent Res 1992;6:120-124.
41. James J, Ferguson MM, Forsyth A, Tulloch N, Lamey PJ. Oral lichenoid reactions related to mercury sensitivity. Br J Oral Maxillofac Surg 1987;25:474-480.
42. Jameson MW, Kardos TB, Kirk EE, Ferguson MM. Mucosal reactions to amalgam restorations. J Oral Rehab 1990;17:293-301.
43. Lind PO. Oral lichenoid reactions related to composite restorations. Preliminary report. Acta Odontol Scand 1988;45:53-55.
44. Lundstrum IM. Allergy and corrosion of dental materials in patients with oral lichen planus. Int J Oral Surg 1984;13:16-24.
45. Zhu YX. Clinical and histologic analysis of mucous membrane lesions associated with dental restorations. Chin J Stomatol 1989;24:49-53.
46. Allen CM, Blozis GG. Oral mucosal reactions to cinnamin-flavored chewing gum. J Am Dent Assoc 1988;116:664-667.
47. Maibach HI. Cheilitis: Occult allergy to cinnamic aldehyde. Contact Dermatitis 1986;15:106-107.
48. Miller RL, Gould AR, Bernstein ML. Cinnamon-induced stomatitis venenata: Clinical and characteristic histopathologic features. Oral Surg Oral Med Oral Pathol 1992;73:708-716.
49. Katta R. Lichen planus. Am Fam Physician 2000;61:3319-3324,3327-3328.
50. Scalf LA, Fowler JF Jr., Morgan KW, Looney SW. Dental metal allergy in patients with oral, cutaneous, and genital lichenoid reactions. Am J Contact Dermat 2001; 12:146-150.
51. Kirtak N, Inaloz HS, Ozgoztasi, EZ. The prevalence of hepatitis C virus infection in patients with lichen planus in Gaziantep region of Turkey. Eur J Epidemiol 2000;16:1159-1161.
52. Ayala F, Balato N, Tranfaglia A, Guadagnino V, Orlando R. Oral erosive lichen planus and chronic liver disease. J Am Acad Dermatol 1986;14:139-140.
53. Carrozzo M, Gandolfo S, Carbone M, et al. Hepatitis C virus infection in Italian patients with oral lichen planus: A prospective case-control study. J Oral Pathol Med 1996; 25:527-533.
54. Gordon SC. Extrahepatic manifestations of hepatitis C. Digest Dis 1996;14:157-168.
55. Halevy S, Ingber A, Sandbank M. The role of abnormal glucose tolerance, human lymphocyte antigen (HLA) typing, and urolithiasis in lichen planus. J Am Acad Dermatol 1985;13:134.
56. Katz M, Pisanti S. Oral erosive lichen planus and chronic active hepatitis. J Am Acad Dermatol 1985;12:719.
57. Lozada-Nur F, Luangjarmekorn L, Silverman S, Karam J. Assessment of plasma glucose in 99 patients with oral lichen planus. J Oral Med 1985;40:60-61.
58. Mobacken H, Nilsson LA, Olsson R, Sloberg K. Incidence of liver disease in chronic lichen planus of the mouth. Acta Dermatol Venereol 1984;64:70-73.
59. Pawlotsky JM, Dhumeaux D, Bagot M. Hepatitis C virus in dermatology. A review. Arch Dermatol 1995;131:1185-1193.
60. Scully C, Potts AJC, Hamburger J, Wiesenfuld D, McKee JI, El Kom M. Lichen planus and liver disease: How strong is the association? J Oral Pathol 1985;14:224-226.
61. Lunel F, Cacoub P. Treatment of autoimmune and extrahepatic manifestations of HCV infection. Ann Med Interne (Paris) 2000;151:58-64.
62. Varela P, Areias J, Mota F, Canelhas A, Sanches M. Oral lichen planus induced by interferon-alpha-N1 in a patient with hepatitis C. Int J Dermatol 2000;39:239-240.
63. Lodi G, Porter SR, Scully C. Hepatitis C virus infection. Review and implications for the dentist. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:8-22.
64. Bagan JV, Ramon C, Gonzalez L, et al. Preliminary investigation of the association of oral lichen planus and hepatitis C. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:532-536.
65. Mattsson, T, Sundqvist, KG, Heimdahl, A, Dahllof G, Ljungman P, Ringden O. A comparative immunological analysis of oral mucosa in chronic graft-versus-host disease and oral lichen planus. Arch Oral Biol 1992;37:539-547.
66. Schubert MM, Sullivan KM. Recognition, incidence, and management of oral graft-versus-host disease. NCI Monogr 1990;9:135-143.
67. Camisa C. Lupus erythematosus/lichen planus overlap syndrome. J Am Acad Dermatol 1984;12:297.
68. Plotnick H, Burnham TK. Lichen planus and coexisting lupus erythematosus versus lichen planus-like lupus erythematosus. J Am Acad Dermatol 1986;14:931-938.
69. Schiodt M. Oral discoid lupus erythematosus. III. A histopathologic study of sixty-six patients. Oral Surg Oral Med Oral Pathol 1984;57:281-293.
70. Schiodt M, Pindborg JJ. Oral discoid lupus erythematosus. I. The validity of previous histopathologic diagnostic criteria. Oral Surg Oral Med Oral Pathol 1984;57:46-51.
71. Pagliaro JA, White S, Strutton G, Guerin D. Lichen planus-like eruption following autologous bone marrow transplantation for chronic myeloid leukaemia. Australas J Dermatol 2001;42:188-191.
72. Nicolatou-Galitis O, Kitra V, Van Vliet-Constantinidou C, et al. The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogenic bone marrow transplant. J Oral Pathol Med 2001;30:148-153.
73. Cawson RA. Management of oral lichen planus. In: McDonald RE, Hurt WC, Gilmore HW, Middleton RA, eds. Current Therapy in Dentistry, vol. 7. St. Louis: The C.V. Mosby Company; 1980:63-68.
74. Balciunas BA, Overholser CD. Diagnosis and treatment of common oral lesions. Am Fam Physician 1987;35:206-220.
75. Pedersen A, Klausen B. Glucocorticosteroids and oral medicine. J Oral Pathol 1984;13:1-15.
76. Hurt WC. Pharmacologic management of stomatologic problems. Dent Clin North Am 1984;28:545-554.
77. Lamey PJ, Boyle MA, Simpson NB, Ferguson MM. A pilot study of griseofulvin therapy in erosive oral lichen planus. J Oral Med 1987;42:233-235.
78. Lozada F. Prednisone and azathioprine in the treatment of oral inflammatory mucocutaneous diseases. Oral Surg Oral Med Oral Pathol 1981;52:257-260
79. Rozycki TW, Rogers RS, Pittelkow MR, et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: A series of 13 patients. J Am Acad Dermatol 2002;46:27-34.
80. Vente C, Reich K, Rupprecht R, Neumann C. Erosive mucosal lichen planus: Response to topical treatment with tacrolimus. Br J Dermatol 1999;140:338-342.
81. Kalrakatsou F, Hodgson TA, Lewsey, JD, et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 2002;46:35-41.
82. Lener EV, Brieva J, Schachter M, West LE, West DP, el-Azhary RA. Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol 2001;137: 419-422.
83. Skaehill PA. Tacrolimus in dermatologic disorders. Ann Pharmacother 2001;35:582-588.
84. Aufdemorte TB, de Villez RL, Gieseker DR. Griseofulvin in the treatment of three cases of oral erosive lichen planus. Oral Surg Oral Med Oral Pathol 1983;55: 459-462.
85. Ho VC, Gupta AK, Ellis BJ, Nickoloff BJ, Voorhees JJ. Treatment of severe lichen planus with cyclosporine. J Am Acad Dermatol 1990;22:64-68.
86. Frances G, Boisnic S, Etienne S, Szpirglas J. Effect of the local application of cyclosporin A on chronic erosive lichen planus of the oral cavity. Dermatologica 1988; 177:194-195.
87. Ferguson MM, Simpson NB, Hammersley N. The treatment of erosive lichen planus with a retinoid-etretinate. Oral Surg Oral Med Oral Pathol 1984;58:283-287.
88. Chan ES, Thornhill M, Azkrzewska J. Interventions for treating oral lichen planus. Cochrane Database Syst Rev 2000;(2):CD001168.
89. Lu SY, Chen WJ, Eng HL. Response to levamisole and low dose prednisolone in 41 patients with chronic oral ulcers: A 3 year open clinical trial and follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:438-445.
90. Buyuk AY, Kavala M. Oral metronidazole treatment of lichen planus. J Am Acad Dermatol 2000;43:260-262.
91. Hodak E, Yosipovitch G, David M, et al. Low-dose low-molecular weight heparin (enoxaparin) is beneficial in lichen planus: A preliminary report. J Am Acad Dermatol 1998;38:564-568.
92. Stefanidou MP, Ioannidou DF, Panayiotides JG, Tosca AD. Low molecular weight heparin: A novel alternative therapeutic approach for lichen planus. Br J Dermatol 1999;141:1040-1045.
93. Nasr IS. Topical tacrolimus in dermatology. Clin Exp Dermatol 2000;25:250-254.
94. Camisa C, Popovsky JL. Effective treatment of oral erosive lichen planus with thalidomide. Arch Dermatol 2000;136:1442-1443.
95. van der Meij EH, Schepman KP, Smeele LE, van der Wal JE, Bezemer PD, van der Waal I. A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:307-310.
96. Lozada-Nur F. Oral lichen planus and oral cancer: Is there enough epidemiologic evidence? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89:265-266.
97. Silverman S Jr. Oral lichen planus: A potentially premalignant lesion. J Oral Maxillofac Surg 2000;58:1286-1288.
98. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: A study of 723 patients. J Am Acad Dermatol 2002;46:207-214.
99. Silverman S, Gorsky M, Lozada-Nur F. A prospective follow-up study of 570 patients with oral lichen planus: Resistance, remission, and malignant association. Oral Surg Oral Med Oral Pathol 1985;60:30-34.
100. Murti PR, Daftary DK, Bhonsle RB, Gupta PC, Mehta FS, Pindborg JJ. Malignant potential of oral lichen planus: Observations in 722 patients from India. J Oral Pathol Med 1986;15:71-77.
101. Holmstrup P, Thorn JJ, Rindum J, Pindborg JJ. Malignant development of lichen planus-affected oral mucosa. J Oral Pathol 1988;17:219-225.
102. Salem G. Oral lichen planus among 4277 patients from Gizan, Saudi Arabia. Community Dent Oral Epidemiol 1989;17:322-324.
103. Sigurgeirsson B, Lindelof B. Lichen planus and malignancy: An epidemiologic study of 2071 patients and a review of the literature. Arch Dermatol 1991;127:1684-1688.
104. Mignogna MD, Lo Muzio L, Lo Russo L, Fedele S, Ruoppo E, Bucci E. Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: A 5-year experience. Oral Oncol 2001; 37:262-267.
105. Kim J, Yook JI, Lee EH, et al. Evaluation of premalignant potential in oral lichen planus using interphase cytogenetics. J Oral Pathol Med 2001;30:65-72.
106. Eisenberg E, Krutchkoff DJ. Lichenoid lesions of oral mucosa: Diagnostic criteria and their importance in the alleged relationship to oral cancer. Oral Surg Oral Med Oral Pathol 1992;73:699-704.
107. Drangsholt M, Truelove EL, Morton TH Jr, Epstein JB. A man with a 30 year history of oral lesions. J Evid Base Dent Pract 2001;2:123-135.
108. Cole WC, Leicht S, Byrd RP Jr, Roy TM. Cicatricial pemphigoid with an upper airway lesion. Tenn Med 2000;93:99-101.
109. Stallmach A, Weg-Remers S, Moser C, Bonkoff H, Feifel G, Zeitz M. Esophageal involvement in cicatricial pemphigoid. Endoscopy 1998;30:657-661.
110. Farrell AM, Kirtschig G, Dalziel KL, et al. Childhood vulval pemphigoid: A clinical and immunopathological study of five patients. Br J Dermatol 1999;140:308-312.
111. Foster CS, Ahmed AR. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: A preliminary study. Ophthalmology 1999;106:2136-2143.
112. Sallout H, Anhalt GJ, Al-Kawas FH. Mucous membrane pemphigoid presenting with isolated esophageal involvement: A case report. Gastrointest Endosc 2000;52:429-433.
113. Ramlogan D, Coulsom IH, McGeorge A. Cicatricial pemphigoid: A diagnostic problem for the urologist. J Royal Coll Surg Edinb 2000;45:62-63.
114. Cheng YS, Rees TD, Wright JM, Plemons JM. Childhood oral pemphigoid: A case report and review of the literature. J Oral Pathol Med 2001;30:372-377.
115. Hardy KM, Perry HO, Pingree GC, Kirby TJ. Benign mucous membrane pemphigoid. Arch Dermatol 1971;104:467-475.
116. Shklar G, McCarthy PL. Oral lesions of mucous membrane pemphigoid. A study of 85 cases. Arch Otolaryngol 1971;3:354-364.
117. Scott JE, Ahmed AR. The blistering diseases. Med Clin North Am 1998;82:1239-1283.
118. Scully C, Carrozzo M, Gandolfo S, Puiatti P, Monteil R. Update on mucous membrane pemphigoid. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:56-68.
119. Silverman S Jr., Gorsky M, Lozada-Nur F, Liu A. Oral mucous membrane pemphigoid. A study of sixty-five patients. Oral Surg Oral Med Oral Pathol 1986;61:233-237.
120. Holsclaw DS. Ocular cicatricial pemphigoid. Int Ophthalmol Clin 1998;38:89-106.
121. Messner EM, Hintschich CR, Partscht K, Messer G, Kampik A. Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications. Ophthalmologe 2000;97:113-120.
122. Leonard JN, Wright P, Haffenden GP, Williams DM, Griffiths CEM, Fry L. Skin diseases and the dry eye. Trans Ophthalmol Soc U K 1985;104:467-476.
123. Baum J. Clinical manifestations of dry eye states. Trans Ophthalmol Soc U K 1985;104:415-423.
124. Lamey PJ, Rees TD, Binnie WH, Rankin KV. Mucous membrane pemphigoid-Treatment experience at two institutions. Oral Surg Oral Med Oral Pathol 1992;74: 50-53.
125. Gallagher G, Shklar G. Oral involvement in mucous membrane pemphigoid. Clin Dermatol 1987;5:18-27.
126. Shklar G, McCarthy PL. Oral lesions of mucous membrane pemphigoid: A study of 85 cases. Arch Otolaryngol 1971;93:354-364.
127. Terezhalmy GT, Bergfeld WF. Cicatricial pemphigoid (benign mucous membrane pemphigoid). Quintessence Int 1998;29:429-437.
128. Setterfield J, Theron J, Vaughan RW, et al. Mucous membrane pemphigoid: HLA-DQB1 *0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br J Dermatol 2001;145:406-414.
129. Rogers RS III, Seehafer JR, Perry HO. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol 1982;6:215-223.
130. Bean SF. Cicatricial pemphigoid. Immunofluorescent studies. Arch Dermatol 1974;110:552-555.
131. Brody HA, Wuepper KA. Mucous membrane pemphigoid-Immunofluorescent studies. J Dent Res 1969; 48:1248-1250.
132. Laskaris G, Demetrios N, Angelopoulos A. Immunofluorescent studies in desquamative gingivitis. J Oral Pathol 1981;10:398-407.
133. Laskaris G, Angelopoulos A. Cicatricial pemphigoid: Direct and indirect immunofluorescent studies. Oral Surg Oral Med Oral Pathol 1981;51:48-52.
134. Laskaris G, Demetrios N, Angelopoulos K. Immunofluorescent studies in desquamative gingivitis. J Oral Pathol 1981;10:398-407.
135. Korman NJ. New immunomodulating drugs in autoimmune blistering diseases. Dermatol Clin 2001;19:637-648. viii
136. Mallet L, Cooper JW, Thomas J. Bullous pemphigoid associated with captopril. DICP 1989;23:63.
137. Ingber A, Grunwald MH, Feuerman EJ. Carbamazepine-induced bullous eruption or bullous pemphigoid? Postgrad Med J 1984;60:307.
138. Van Joost T, Faber WR, Manuel HR. Drug-induced anogenital cicatricial pemphigoid. Br J Dermatol 1980; 102:715-718.
139. Panayiotou BN, Prasad MV, Zaman MN. Furosemide-induced bullous pemphigoid. Br J Clin Pract 1997;51:49-50.
140. Koch CA, Mazzaferri EL, Larry JA, Fanning TS. Bullous pemphigoid after treatment with furosemide. Cutis 1996; 58:340-344.
141. Weller R, White MI. Penicillamine in the etiology of bullous pemphigoid. Ann Pharmacother 1998;32:1368.
142. Bialy-Golan A, Brenner S. Penicillamine-induced bullous dermatoses. J Am Acad Dermatol 1996;35:732-742.
143. Weller R, White MI. Bullous pemphigoid and penicillamine. Clin Exp Dermatol 1996;21:121-122.
144. Joost TV, Crone RA, Overjijk AD. Ocular cicatricial pemphigoid associated with practolol therapy. Br J Dermatol 1976;94:447-450.
145. Miralles J, Barnadas MA, Baselga E, Gelpi C, Rodriquez JL, de Moragas JM. Bullous pemphigoid-like lesions induced by amoxicillin. Int J Dermatol 1997;36:42-47.
146. Fujimoto W, Ishida-Yamamoto A, Hsu R, et al. Antiepiligrin cicatricial pemphigoid: A case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita. Br J Dermatol 1998;139:682-687.
147. Setterfield J, Shirlaw PJ, Lazarova Z, et al. Paraneoplastic cicatricial pemphigoid. Br J Dermatol 1999;141:127-131.
148. Ciarrocca KN, Greenberg MS. A retrospective study of the management of oral mucous membrane pemphigoid with dapsone. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:159-163.
149. Rogers RS, Mehregan DA. Dapsone therapy of cicatricial pemphigoid. Semin Dermatol 1988;7:201-205.
150. Lever WF. Pemphigus and pemphigoid. A review of the advances made since 1964. Am J Dermatopathol 1979;1:2-32.
151. Gorlin RJ. Vesiculo-bullous lesions. Gerodontics 1985; 1:105-107.
152. Lu SY, Chen WJ, Eng HL. Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers: A 3-year open clinical trial and follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:438-445.
153. Thornfeldt CR, Menkes AW. Bullous pemphigoid controlled by tetracycline. J Am Acad Dermatol 1987;16:305-310.
154. Kreyden OP, Borradori L, Trueb RM, Burg G, Nestle FO. Successful therapy with tetracycline and nicotinamide in cicatricial pemphigoid. Hautarzt 2001;52:247-250.
155. Reiche L, Wojnarowska F, Mallon E. Combination therapy with nicotinamide and tetracyclines for cicatricial pemphigoid: Further support for its efficacy. Clin Exp Dermatol 1998;23:254-257.
156. Damoulis PD, Gagari E. Combined treatment of periodontal disease and benign mucous membrane pemphigoid. Case report with 8 years maintenance. J Periodontol 2000;71:1620-1629.
157. Korman N. Pemphigus. J Am Dermatopathol 1988;18:1219-1238.
158. Orlowski WA, Bressman E, Doyle JL, Chasens AI. Chronic pemphigus vulgaris of the gingiva. A case report with a 6-year follow-up. J Periodontol 1983;54:685-689.
159. Markitziu A, Pisanty S. Gingival pemphigus vulgaris. Report of a case. Oral Surg Oral Med Oral Pathol 1983;55:250-253.
160. Mashkilleyson N, Mashkilleyson AL. Mucous membrane manifestations of pemphigus vulgaris. Acta Derm Venereol 1988;68:413-421.
161. Sirois D, Leigh JE, Sollecito TP. Oral pemphigus vulgaris preceding cutaneous lesions: Recognition and diagnosis. J Am Dent Assoc 2000;131:1156-1160.
162. Mignogna MD, Lo Muzio L, Bucci E. Clinical features of gingival pemphigus vulgaris. J Clin Periodontol 2001;28:489-493.
163. Coscia-Porrazzi L, Maiello FM, Ruocco V, Pisani M. Cytodiagnosis of oral pemphigus vulgaris. J Acta Cytol 1985;29:746-749.
164. Stanley JR, Yaar M, Hawley-Nelson P, Katz SI. Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest 1982;70:281-288.
165. Marinho RT, Johnson NW, Fatela NM, et al. Oropharyngeal pemphigus in a patient with chronic hepatitis C during interferon alpha-2a therapy. Eur J Gastroenterol Hepatol 2001;13:869-872.
166. Hsiao CJ, Hsu MM, Lee JY, Chen WC, Hsieh WC. Paraneoplastic pemphigus in association with a retroperitoneal Castleman's disease presenting with a lichen planus pemphigoides-like eruption. A care report and review of the literature. Br J Dermatol 2001;144: 372-376.
167. Allen CM, Camisa C. Paraneoplastic pemphigus: A review of the literature. Oral Dis 2000;6:208-214.
168. van der Waal RI, Pas HH, Nousari HC, et al. Paraneoplastic pemphigus caused by an epitheloid leiomyosarcoma and associated with fatal respiratory failure. Oral Oncol 2000;36:390-393.
169. Correll AW, Schott TR. Multiple, painful vesiculoulcerative lesions in the oral mucosa. J Am Dent Assoc 1985;110:765-766.
170. Ferguson CD, Taybos GM. Diagnosis and treatment of pemphigus. Quintessence Int 1985;7:473-476.
171. Lamey PJ, Rees TD, Wright JM, Simpson NB. Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy. Oral Surg Oral Med Oral Pathol 1992;74:54-57.
172. Mignogna MD, Lo Muzio L, Mignogna RE, Carbone R, Ruoppo E, Bucci E. Oral pemphigus: Long-term behavior and clinical response to treatment with deflazacort in sixteen cases. J Oral Pathol Med 2000;29:145-152.
173. Basset N, Guillot B, Michel B, Meynadier J, Guilhou JJ. Dapsone as initial treatment in superficial pemphigus. Report of nine cases. Arch Dermatol 1987;123:783-785.
174. Page EH, Wexler DM, Guenther LC. Cyclosporin A. J Am Dermatopathol 1986;14:785-791.
175. Zhu JF, Kaminski MJ, Pulitzer DR, Hu J, Thomas HF. Psoriasis: Pathophysiology and oral manifestations. Oral Dis 1996;2:135-144.
176. Richardson LJ, Kratochvil FJ, Zieper MB. Unusual palatal presentation of oral psoriasis. J Can Dent Assoc 2000;66:80-82.
177. Matarasso S, Vaia E, Fusco A, Riccitiello F, Nicolo M. Desquamative gingivitis: Etiopathogenetic and clinical assessment. Minerva Stomatol 1989;38:359-368.
178. Younai FS, Phelan JA. Oral mucositis with features of psoriasis: Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:61-67.
179. Zunt SL, Tomich CE. Eythema migrans - A psoriaform lesion of the oral mucosa. J Dermatol Surg Oncol 1989; 15:1067-1070.
180. Brice DM, Danesh-Meyer MJ. Oral lesions in patients with psoriasis: Clinical presentation and management. J Periodontol 2000;71:1896-1903.
181. Yamada J, Amar S, Petrungaro P. Psoriasis-associated periodontitis: A case report. J Periodontol 1992;63:854-857.
182. Pogrel MA, Cram D. Intraoral findings in patients with psoriasis with a special reference to ectopic geographic tongue (erythema circinata). Oral Surg Oral Med Oral Pathol 1989;66:184-189.
183. Femiano F. Geographic tongue (migrant glossitis) and psoriasis. Minerva Stomatol 2001;50:213-217.
184. Morris LF, Phillips CM, Binnie WH, Sander HM, Silverman AK, Mento MA. Oral lesions in patients with psoriasis: A controlled study. Cutis 1992;49:339-344.
185. Espelid M, Bang G, Johannessen AC, Leira JI, Christensen O. Geographic stomatitis: Report of 6 cases. J Oral Pathol Med 1991;20:425-428.
186. Ulmansky M, Michelle R, Azaz B. Oral psoriasis: Report of six new cases. J Oral Pathol Med 1995;24:42-45.
187. Koo JY. Current consensus and update on psoriasis therapy: A perspective from the U.S. J Dermatol 1999;26:723-733.
188. Geilen CC, Arnold M, Orfanos CE. Mycophenolate mofetil as a systemic antipsoriatic agent: Positive experience in 11 patients. Br J Dermatol 2001;144:583-586.
189. Eisen D, Essell J, Broun ER. Oral cavity complications of bone marrow transplantation. Semin Cutan Med Surg 1997;16:265-272.
190. Hiroki A, Nakamura S, Shinohara M, Oka M. Significance of oral examination in chronic graft-versus-host disease. J Oral Pathol Med 1994;23:209-215.
191. Nakamura S, Hiroki A, Shinohara M, et al. Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation. Oral Surg Oral Med Oral Pathol Oral Radial Endod 1996;82:556-563.
192. Eggleston TI, Ziccardi VB, Lumerman H. Graft-versus-host disease. Case report and discussion. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86:692-696.
193. Holmstrup P. Non-plaque-induced gingival lesions. Ann Periodontol 1999;4:20-31.
194. Majorana A, Schubert MM, Porta F, Ugazio AG, Sapelli PL. Oral complications of pediatric hematopoietic cell transplantation: Diagnosis and management. Support Care Cancer 2000;8:353-365.
195. McCartan BE, McCreary CE. Oral lichenoid drug eruptions. Oral Dis 1997;3:58-63.
196. Curtis JW Jr., Caughman GB. An apparent unusual relationship between rampant caries and oral mucosal manifestations of chronic graft-versus-host disease. Oral Surg Oral Med Oral Pathol 1994;78:267-272.
197. Epstein JB, Reece DE. Topical cyclosporin A for treatment of oral chronic graft-versus-host disease. Bone Marrow Transplant 1994;13:81-86.
198. Epstein JB, Nantel S, Sheoltch SM. Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease. Bone Marrow Transplant 2000;25:683-687.
199. Epstein JB, Gorsky M, Epstein MS, Nantel S. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: A series of cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:56-61.
200. Jaremko WM, Beutner EH, Kumar V, et al. Chronic ulcerative stomatitis associated with a specific immunologic marker. J Am Acad Dermatol 1990;22: 215-220.
201. Chlorzelski TP. Chronic ulcerative stomatits (CUS): A new disease entity with a specific immunological marker (SES-ANA) (in Polish). Przegl Dermatol 1990; 77:229-232.
202. Beutner EH, Chorzelski TP, Parodi A, et al. Ten cases of chronic ulcerative stomatitis with stratified epithelium-specific antinuclear antibody. J Am Acad Dermatol 1991;24:781-782.
203. Church LF Jr., Schosser RH. Chronic ulcerative stomatitis associated with stratified epithelium specific antinuclear antibody. A case report of a newly described disease entity. Oral Surg Oral Med Oral Pathol 1992; 73:579-582.
204. Lewis JE, Beutner EH, Rostami R, Chorzelski TP. Chronic ulcerative stomatitis with stratified epithelium-specific antinuclear antibodies. Int J Dermatol 1996;35:272-275.
205. Worle B, Wollenberg A, Schaller M, Kunzelmann KH, Plewig G, Meurer M. Chronic ulcerative stomatitis. Br J Dermatol 1997;137:262-265.
206. Chorzelski TP, Olszewska M, Jarzabek-Chorzelski M, Jablonska S. Is chronic ulcerative stomatitis an entity? Clinical and immunological findings in 18 cases. Eur J Dermatol 1998;8:261-265.
207. Lorenzana ER, Rees TD, Glass M, Detweiler JG. Chronic ulcerative stomatitis: A case report. J Periodontol 2000;71:104-111.
208. Gammon WR, Briggaman RA. Bullous SLE: A phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol 1993;100:28-34.
209. Ginzler EM, Antoniadis I. Clinical manifestations of systemic lupus erythematosus, measures of disease activity, and long-term complications. Curr Opin Rheumatol 1992;4:672-680.
210. Lee LA. Neonatal lupus erythematosus. J Invest Dermatol 1993;100:9-13.
211. Condemi JJ. The autoimmune diseases. JAMA 1987; 258:2920-2929.
212. McCauliffe DP. Cutaneous lupus erythematosus. Semin Cutan Med Surg 2001;20:14-26.
213. Meyer U, Kleinheinz J, Handschel J, Kruse-Losler B, Weingart D, Joos U. Oral findings in three different groups of immunocompromised patients. J Oral Pathol Med 2000;29:153-158.
214. Meyer U, Kleinheinz J, Gaubitz M, Schulz M, Weingart D, Joos U. Oral manifestations in patients with systemic lupus erythematosus. Mund Kiefer Gesichtschir 1997;1:90-94.
215. Jorizzo JL, Salisbury PL, Rogers RS, et al. Oral lesions in systemic lupus erythematosus. Do ulcerative lesions represent a necrotizing vasculitis? J Am Acad Dermatol 1992;27:389-394.
216. Burge SM, Frith PA, Juniper RP, Wojnarowska F. Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br J Dermatol 1989;121:727-741.
217. Bonaccorso A, Tripi TR. Oral lesions in systemic lupus erythematosus. I. The etiopathogenic aspects of lupus erythematosus. Minerva Stomatol 1998;47:27-31.
218. Reibel J, Schiodt M. Immunohistochemical studies on colloid bodies (Civatte bodies) in oral lesions of discoid lupus erythematosus. Scand J Dent Res 1986;94:536-544.
219. Heule F, van Joost T, Beukers R. Cyclosporine in the treatment of lupus erythematosus. Arch Dermatol 1986;122:973-974.